Clinical features and natural history of progressive supranuclear palsy - A clinical cohort study

被引:168
|
作者
Nath, U
Ben-Shlomo, Y
Thomson, RG
Lees, AJ
Burn, DJ
机构
[1] Univ Newcastle Upon Tyne, Sch Hlth Sci, Dept Neurol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] Univ Newcastle Upon Tyne, Sch Hlth Sci, Dept Epidemiol & Publ Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[3] Univ Bristol, Dept Social Med, Bristol BS8 1TH, Avon, England
[4] Reta Lila Weston Inst Neurol Sci & Sara Koe PSP R, Inst Neurol, London, England
关键词
D O I
10.1212/01.WNL.0000052991.70149.68
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To describe clinical features and identify prognostic predictors in progressive supranuclear palsy (PSP) Methods: Record-based diagnosis according to National Institute of Neurological Disorders and Stroke-Society for Progressive Supranuclear Palsy criteria was performed in 187 cases of PSP. Clinical information was abstracted from patient records. Sixty-two patients (33%) were examined by the investigators. Forty-nine of 62 patients (79%) underwent standardized clinical assessment. Predictors of survival were examined after a mean of 6.4 years. Results: The most common symptoms at disease onset related to mobility (69%). Of patients undergoing standardized clinical assessment, diplopia occurred in 61%, photophobia in 43%, and eyelid apraxia in 43%. Seventy-five cases (40%) died during follow-up. Older age at onset and classification as probable PSP were associated with poorer survival. Onset of falls (hazard ratio 3.28, 95% CI 1.17 to 9.13), speech problems (hazard ratio 4.74, 95% CI 1.10 to 20.4), or diplopia (hazard ratio 4.23, 95% CI 1.23 to 14.6) within 1 year and swallowing problems within 2 years (hazard ratio 3.91, 95% CI 1.39 to 11.0) were associated with a worse prognosis. Conclusions: Mobility problems are the commonest early feature in PSP and visual symptoms are often functionally disabling. Early falls, speech and swallowing problems, diplopia, and early insertion of a percutaneous gastrostomy predict reduced survival.
引用
收藏
页码:910 / 916
页数:7
相关论文
共 50 条
  • [1] Natural history and clinical features of progressive supranuclear palsy: a clinical study
    Diroma, C
    Dell'Aquila, C
    Fraddosio, A
    Lamberti, S
    Mastronardi, R
    Russo, I
    De Mari, M
    Iliceto, G
    [J]. NEUROLOGICAL SCIENCES, 2003, 24 (03) : 176 - 177
  • [2] Natural history and clinical features of progressive supranuclear palsy: a clinical study
    C. Diroma
    C. Dell’Aquila
    A. Fraddosio
    S. Lamberti
    R. Mastronardi
    I. Russo
    M. De Mari
    G. Iliceto
    [J]. Neurological Sciences, 2003, 24 : 176 - 177
  • [3] Progressive supranuclear palsy: a clinical, natural history and disability study
    Macia, F
    Ballan, G
    Yekhlef, F
    Delmer, O
    Vital, C
    Lagueny, A
    Tison, F
    [J]. REVUE NEUROLOGIQUE, 2003, 159 (01) : 31 - 42
  • [4] Clinical features of progressive supranuclear palsy
    Wen, Yafei
    Yang, Qijie
    Jiao, Bin
    Zhang, Weiwei
    Lin, Jingyi
    Zhu, Yuan
    Xu, Qian
    Zhou, Hui
    Weng, Ling
    Liao, Xinxin
    Zhou, Yafang
    Wang, Junling
    Guo, Jifeng
    Yan, Xinxiang
    Jiang, Hong
    Tang, Beisha
    Shen, Lu
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [5] Clinical and Pathological Features of Progressive Supranuclear Palsy with Family History
    Fujioka, Shinsuke
    Algom, Avi
    Strongosky, Audrey
    Dickson, Dennis W.
    Wszolek, Zbigniew K.
    [J]. ANNALS OF NEUROLOGY, 2011, 70 : S45 - S45
  • [6] Progressive supranuclear palsy: Clinical features, natural history and treatment with symptomatic drugs in 16 patients
    Solla, P.
    Cannas, A.
    Secchi, L.
    Congia, S.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 108 - 109
  • [7] Correlation of Clinical and Neuroimaging Features in Progressive Supranuclear Palsy
    French, David
    Dewey, Richard
    Khemani, Pravin
    [J]. NEUROLOGY, 2017, 88
  • [8] Progressive supranuclear palsy - Clinical features, pathophysiology and management
    Rajput, A
    Rajput, AH
    [J]. DRUGS & AGING, 2001, 18 (12) : 913 - 925
  • [9] Clinical features and criteria for the diagnosis of progressive supranuclear palsy
    Williams, David R.
    Lee, Will
    [J]. NEURODEGENERATIVE DISEASE MANAGEMENT, 2012, 2 (01) : 125 - 133
  • [10] Clinical and Neuropsychological features in patients with Progressive Supranuclear Palsy
    Kobylecki, Christopher
    Jones, Matthew
    Thompson, Jennifer C.
    Richardson, Anna M.
    Neary, David
    Snowden, Julie S.
    Gerhard, Alexander
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 33 : 221 - 222